Biotech specialises in autoimmune disorder drugs.
Companies to develop bispecific antibodies.
David Ricks revamps organisation after trial disappointment.
Examining the views of different stakeholders in the ecosystem supporting drug R&D.
Gilead makes key hiring amid M&A rumours.
Roche hopes to take on Novo Nordisk and Shire.
BMS to pay up to $936m for NG-348.
Exhibition & Conference for Pharma Professionals